Researchers at Tulane University have illuminated a path toward preventing the transmission of cytomegalovirus (CMV), a common virus that poses severe risks during pregnancy. Their study not only sheds light on why pre-existing immunity matters but also offers hope for the development of a potential CMV vaccine, bringing us closer to safeguarding the health of both mothers and their unborn babies.
1 Like